| Literature DB >> 33987311 |
Maria Yan1, Samyd S Bustos1,2, Doga Kuruoglu1,2, Pedro Ciudad3, Antonio J Forte4, Esther A Kim5, Gabriel Del Corral6, Oscar J Manrique1,2.
Abstract
Transgender patients often desire to have biological children. However, their reproductive potential is often negatively impacted by gender affirming surgery (GAS) such as gender confirmation surgery (bottom surgery) and medical hormone therapy. Therefore, counselling patients on fertility preservation options before initiating gender-affirming treatments is prudent to avoid reducing their reproductive potential. A systematic review of English, Spanish, Chinese, French and Turkish languages from 2000 to December 23rd, 2019, using the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) guidelines, was conducted. The search strategy was designed and conducted by an experienced librarian with input from the study's principle investigator. Fifteen articles that report outcomes of fertility preservation options in transgenders were included. Eight articles described options for transgender women, six reported options for transgender men and one included both transgender women and transgender men. Semen cryopreservation and oocyte cryopreservation are the most common and available methods for fertility preservation in transgenders. Physician awareness of fertility preservation options in transgender patients is crucial to ensure informed discussions regarding reproductive options in the early phase of transition. 2021 Annals of Translational Medicine. All rights reserved.Entities:
Keywords: Fertility preservation; fertilization; plastic surgery; reproductive techniques; transgender persons
Year: 2021 PMID: 33987311 PMCID: PMC8105795 DOI: 10.21037/atm-20-4523
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839